Formaldehyde → 2-[1-(1-Methyl-4-(tert-butyloxycarbonyl)piperazine-2-yl)-ethylamino]-4-[benzimidazol-1-yl]-pyrimidine
Reaction equation
[C:1]([O:5][C:6]([N:8]1[CH2:13][CH2:12][NH:11][CH:10]([CH:14]([NH:16][C:17]2[N:22]=[C:21]([N:23]3[C:27]4[CH:28]=[CH:29][CH:30]=[CH:31][C:26]=4[N:25]=[CH:24]3)[CH:20]=[CH:19][N:18]=2)[CH3:15])[CH2:9]1)=[O:7])([CH3:4])([CH3:3])[CH3:2].[BH3-][C:33]#N.[Na+].C=O.O>CO.CC#N.CCOC(C)=O>[CH3:33][N:11]1[CH2:12][CH2:13][N:8]([C:6]([O:5][C:1]([CH3:2])([CH3:3])[CH3:4])=[O:7])[CH2:9][CH:10]1[CH:14]([NH:16][C:17]1[N:22]=[C:21]([N:23]2[C:27]3[CH:28]=[CH:29][CH:30]=[CH:31][C:26]=3[N:25]=[CH:24]2)[CH:20]=[CH:19][N:18]=1)[CH3:15]Participants
8
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
To a solution of 2-[1-(4-(tert-butyloxycarbonyl)piperazine-2-yl)-ethylamino]-4-(benzimidazol-1-yl)-pyrimidine (EXAMPLE 17, Step C; 17 mg) in 1 mL of MeOH and 1 mL of CH3CN was added NaBH3CN (5 mg) and 37% aqueous formaldehyde (20 μL). The mixture was stirred overnight at room temperature, then diluted with 5 mL of EtOAc and poured into 10 mL of water. The phases were separated and the aqueous phase was extracted with 2×5 mL of EtOAc. The aqueous phase was basified (pH>10) by addition of 5 N NaOH, then extracted with 5×5 mL of EtOAc. The combined organic extracts were washed with 5 mL of brine, dried over Na2SO4, and concentrated to yield 15 mg of the title compound.
Workup
- customThe phases were separated
- extractionthe aqueous phase was extracted with 2×5 mL of EtOAc
- additionby addition of 5 N NaOH
- extractionextracted with 5×5 mL of EtOAc
- washThe combined organic extracts were washed with 5 mL of brine
- dry with materialdried over Na2SO4
- concentrationconcentrated
Sources & evidence
- ORD record
- ord-331fd465e6c74bb8b7f3607689911ab5
- Source dataset
- uspto-grants-2001_11
- Patent number
- US06316444B1
Reaction notes
Loading…